Human Virology and Viral Diseases
A section of Viruses (ISSN 1999-4915).
Section Information
Viruses have caused some of the most dramatic and deadly disease pandemics and epidemics the world has known. Subsequently, most of these causing agents have become common viruses with different epidemiological trends. The most recent trend has focused on emerging and re-emerging viruses and our related preparedness and response aspects. However, human virology goes beyond (re)-emerging viral diseases. This section aims at addressing all aspects of human viruses, medical virology and virus-induced clinical diseases. All types of manuscripts addressing a broad range of topics including epidemiology, prevention, diagnostics and treatment, will be considered in this section. Manuscripts must represent original and significant contributions.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Progress and Prospects in Oncolytic Virotherapy (Deadline: 28 February 2025)
- Preparation for the Next Potential Pandemic—Chikungunya, Dengue, Zika and Other Viruses (Deadline: 28 February 2025)
- Hepatitis E: Molecular Virology, Pathogenesis, and Treatment, 2nd Edition (Deadline: 28 February 2025)
- Viruses and Eye Diseases (Deadline: 28 February 2025)
- Viral Hepatitis Coinfection (Deadline: 28 February 2025)
- Viral Infections in Special Populations (Deadline: 28 February 2025)
- Mosquito-Borne Encephalitis Viruses (Deadline: 28 February 2025)
- Mpox (Monkeypox): From Neglected Tropical Disease to Emerging Global Pathogen (Deadline: 1 March 2025)
- Epidemiology, Pathogenesis and Immunity of Adenovirus (Deadline: 6 March 2025)
- BSL4 Viruses: Understanding and Controlling Highly Infectious Pathogens (Deadline: 15 March 2025)
- Current ART, Virologic Failure and Implications for HIV Drug Resistance, 2nd Edition (Deadline: 31 March 2025)
- RSV Epidemiological Surveillance: 2nd Edition (Deadline: 31 March 2025)
- HIV Vaccines: Bridging the Gap Between Basic Science and Clinical Practice (Deadline: 31 March 2025)
- HIV-1 Infection and Immunometabolism: Relevance to HIV Pathogenesis and Persistence 3.0 (Deadline: 31 March 2025)
- Emerging and Re-emerging Infections: Impact on Substances of Human Origin (SoHO) (Deadline: 31 March 2025)
- Advances in Research on HIV Drug Resistance and Other Determinants of Treatment Success: 3rd Edition (Deadline: 31 March 2025)
- Viruses Associated with Gastroenteritis (Deadline: 31 March 2025)
- Understanding the Oncogenesis of Human Herpesviruses through Their Critical Comparisons (Deadline: 25 April 2025)
- Hepatitis B Core-Related Antigen (Deadline: 30 April 2025)
- Congenital Cytomegalovirus Infection: Volume II (Deadline: 30 April 2025)
- Intra-patient Viral Evolution (Deadline: 30 April 2025)
- Hepatitis B Surface Antigen: A Pivotal Role in the Virus–Host Interactions (Deadline: 30 April 2025)
- EBV and Disease: New Perspectives in the Post COVID-19 Era (Deadline: 30 April 2025)
- Human Cytomegalovirus Therapeutic Strategies and Clinical Applications (Deadline: 30 April 2025)
- Molecular and Cellular Biology of Human Oncogenic Viruses (Deadline: 30 April 2025)
- Coxsackieviruses, Polioviruses and Associated Diseases (Second Edition) (Deadline: 1 May 2025)
- Hantavirus 2024 (Deadline: 16 May 2025)
- Research and Clinical Application of Adenovirus (AdV), 3rd Edition (Deadline: 25 May 2025)
- HIV Neurological Disorders: 2nd Edition (Deadline: 30 May 2025)
- Endogenous Retrovirus Proteins and Their Functions, 2nd Edition (Deadline: 30 May 2025)
- Severe Fever with Thrombocytopenia Syndrome Virus 2025 (Deadline: 31 May 2025)
- TMPRSS2 in Influenza Virus and Coronavirus Infections (Deadline: 31 May 2025)
- Human T-Cell Leukemia Virus (HTLV) Infection and Treatment (Deadline: 31 May 2025)
- Measles, Mumps, and Rubella (Deadline: 31 May 2025)
- Oropouche Virus (OROV): An Emerging Peribunyavirus (Bunyavirus) (Deadline: 1 June 2025)
- Long-Acting Antiretrovirals (Deadline: 15 June 2025)
- Viral Hepatitis and Liver Diseases (Deadline: 30 June 2025)
- Viral Infection and Platelets’ Disorders (Deadline: 30 June 2025)
- Immune Modulation by Human Cytomegalovirus (Deadline: 30 June 2025)
- Advancing Research of Anelloviruses, Second Edition (Deadline: 30 June 2025)
- Virological and Immunological Factors Underlying HBV Functional Cure and HBV Reactivation (Deadline: 30 June 2025)
- Immune Responses to Papillomavirus Infections: 2nd Edition (Deadline: 30 June 2025)
- Beyond Acute: Navigating Long COVID and Post-Viral Complications (Deadline: 30 June 2025)
- Maternal to Child Transmission of HIV and the Effects on Pregnancy (Deadline: 31 July 2025)
- HIV Assembly, Release and Maturation (Deadline: 31 July 2025)
- Cascade of Care for HIV, Hepatitis and Sexually Transmitted Infections (Deadline: 31 July 2025)
- HIV: From Molecular Biology of Latency to Novel Cure Strategies (Deadline: 31 July 2025)
- Herpesviruses and Associated Diseases (Deadline: 31 July 2025)
- Novel Strategies to Identify and Eliminate Latent HIV Cells (Deadline: 31 July 2025)
- Human Adenovirus (HAdV) Infection in Children (Deadline: 31 July 2025)
- An Update on Enterovirus Research, 2nd Edition (Deadline: 31 July 2025)
- Lytic Cycle of Herpesviruses and the Associated Pathogenesis (Deadline: 31 August 2025)
- Translational Research in Virology (Deadline: 31 August 2025)
- Navigating Viral Threats: Enteric and Respiratory Viral Challenges in the Post-COVID-19 Era (Deadline: 31 August 2025)
- Viral Immunology in Transplant Patients (Deadline: 31 August 2025)
- Viral Infections in Gynecological Diseases (Deadline: 31 August 2025)
- Human and Animal Papillomavirus: Infections, Genetics, and Vaccines (Deadline: 10 September 2025)
- HIV and HTLV Infections and Coinfections (Deadline: 30 September 2025)
- Enteric Viruses in Environment and Humans: Identification, Surveillance and Control (Deadline: 31 October 2025)
- Neurocognitive Dynamics and Biomarkers in HIV (Deadline: 1 November 2025)
- Enveloped and Non-Enveloped Virus Assembly (Deadline: 30 November 2025)
- Molecular Mechanisms and Clinical Manifestations of Persistent Viral Infections (Deadline: 30 November 2025)
- Advancing Hepatitis Elimination: HBV, HDV, and HCV (Deadline: 31 December 2025)
- HIV Reservoirs, Latency, and the Factors Responsible (Deadline: 31 December 2025)
- HIV and Drugs of Abuse, 4th Edition (Deadline: 31 January 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
